Gandia, Peggy <br/><br/>
Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers.  [electronic resource] 

 -  Journal of clinical pharmacology  Mar 2007 
 - 334-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Standard No.: </label>10.1177/0091270006296522  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylglucosaminidase--urine<br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Area Under Curve<br/>Asthenia--chemically induced<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Glutathione Transferase--urine<br/>Headache--chemically induced<br/>Humans<br/>Male<br/>Mesalamine--administration & dosage<br/>Middle Aged<br/>Nausea--chemically induced<br/>Proteinuria--chemically induced<br/>Tablets, Enteric-Coated<br/>Therapeutic Equivalency<br/>Time Factors<br/>beta 2-Microglobulin--urine